Trademark: 88636106
Status Date
Tuesday, November 29, 2022
Registration Number
6909259
Registration Date
Tuesday, November 29, 2022
Filing Date
Monday, September 30, 2019
Published for Opposition
Tuesday, September 14, 2021
5 Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
1 Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use
42 Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering
The mark consists of two interlocking circles. One circle is yellow and the other circle is red. Where the circles interlock, they are orange. The outer edges of the circles are thinner than the inner portions of the circles. The colour white represents the background, outlining, shading and/or transparent area and is not part of the mark.
The color(s) yellow, orange, and red is/are claimed as a feature of the mark.
Nov 29, 2022
Notice Of Registration Confirmation Emailed
Nov 29, 2022
Registered-Principal Register
Oct 26, 2022
1(B) Basis Deleted; Proceed To Registration
Oct 10, 2022
Notice Of Allowance Cancelled
Oct 26, 2022
Case Assigned To Intent To Use Paralegal
Oct 10, 2022
Teas Delete 1(B) Basis Received
May 11, 2022
Notice Of Approval Of Extension Request E-Mailed
May 9, 2022
Sou Extension 1 Granted
May 9, 2022
Sou Extension 1 Filed
May 9, 2022
Teas Extension Received
Jan 27, 2022
Teas Change Of Correspondence Received
Jan 27, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 27, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 9, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Published For Opposition
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 10, 2021
Approved For Pub - Principal Register
Jul 6, 2021
Suspension Checked ¿ To Attorney For Action
May 13, 2021
Teas Response To Suspension Inquiry Received
Jul 29, 2020
Notification Of Letter Of Suspension E-Mailed
Jul 29, 2020
Letter Of Suspension E-Mailed
Jul 29, 2020
Suspension Letter Written
Jul 3, 2020
Teas/Email Correspondence Entered
Jul 3, 2020
Correspondence Received In Law Office
Jul 3, 2020
Teas Response To Office Action Received
Jan 3, 2020
Notification Of Non-Final Action E-Mailed
Jan 3, 2020
Non-Final Action E-Mailed
Jan 3, 2020
Non-Final Action Written
Jan 3, 2020
Assigned To Examiner
Oct 4, 2019
Notice Of Design Search Code E-Mailed
Oct 3, 2019
New Application Office Supplied Data Entered In Tram
Oct 3, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
